Download PDF
Thromb Haemost 1968; 19(01/02): 129-135
DOI: 10.1055/s-0038-1651189
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Coagulation Factors and Components of the Fibrinolytic System in Lymph and Blood in Dogs

L Leandoer
1   Department of Surgery I, University of Göteborg, Sahlgrenska Sjukhuset, Göteborg
2   Coagulation Laboratory, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
,
S.-E Bergentz
1   Department of Surgery I, University of Göteborg, Sahlgrenska Sjukhuset, Göteborg
2   Coagulation Laboratory, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
,
Inga Marie Nilsson
1   Department of Surgery I, University of Göteborg, Sahlgrenska Sjukhuset, Göteborg
2   Coagulation Laboratory, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
› Author AffiliationsThis investigation was supported by grants from the Swedish Medical Research Council (B67-17X-759-02, B67-19X-87-03).
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

Thoracic duct lymph of the dog was compared with blood regarding the concentration of various coagulation factors, coagulation properties, and components of the fibrinolytic system.

The recalcification time for lymph was almost twice as long as for blood. The quotients between the concentration of the coagulation factors in the lymph and blood varied considerably. For fibrinogen the lymph/blood concentration ratio was 1/3, for factor V 1/4, for factor VIII 1/4, for factor IX 2/3 and for P & P 1/2.

The fibrinolytic activity in the lymph was lower than in the blood and no split products were found in the lymph. The lymph/blood concentration ratio was 1/2 for plasminogen and 2/3 for the urokinase inhibitor activity.

 

  • References

  • 1 Andersson L, Nilsson I.M, Olow B. Fibrinolytic activity in man during surgery. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 7: 391
    PubMedGoogle Scholar
  • 2 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem 1952; 40: 346
    CrossrefPubMedGoogle Scholar
  • 3 Bergström K, Werner B. Proteins in human thoracic duct lymph. Acta chir. scand. 1966; 131: 413
    PubMedGoogle Scholar
  • 4 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv Kemi 1956; 10: 415
    PubMedGoogle Scholar
  • 5 Blomstrand R, Nilsson I.M, Dahlbäck O. Coagulation studies on human thoracic duct lymph. Scand. J. clin. Lab. Invest. 1963; 15: 248
    CrossrefPubMedGoogle Scholar
  • 6 Brinkhous K.M, Walker S.A. Prothrombin and fibrinogen in lymph. Amer. J. Physiol. 1941; 132: 666
    PubMedGoogle Scholar
  • 7 Fantl P, Nelson J.F. Coagulation in lymph. J. Physiol. 1953; 122: 33
    CrossrefPubMedGoogle Scholar
  • 8 Gram H.C. Studier over fibrinmengden i menniskets blod og plasma. Steen Hasselbacks førlag, Kobenhavn 1921
    PubMed
  • 9 Greig H.B.W. Inhibition of fibrinolysis by alimentary lipaemia. Lancet 1956; II: 16
    PubMedGoogle Scholar
  • 10 Grotte G. Passage of dextran molecules across the blood-lymph barrier. Acta chir. scand., Suppl. 211 1956
    PubMed
  • 11 Hansen H.G, Aepinus K. Gerinnungsfaktoren in der Lymphe. Thrombos. Diathes. haemorrh. (Stuttg.) 1960; 4: 435
    PubMedGoogle Scholar
  • 12 Hansen H.G, Kämpfer M. Gerinnungsfaktoren in der Lymphe. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 7: 106
    PubMedGoogle Scholar
  • 13 Hedner U, Nilsson I.M. Determination of plasminogen in human plasma by a casein method. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 14: 545
    PubMedGoogle Scholar
  • 14 Howell W.H. The coagulation of lymph. Amer. J. Physiol. 1914; 35: 483
    PubMedGoogle Scholar
  • 15 Jacobsson, B.: To be published.
    PubMed
  • 16 von Kaulla K.N, Pratt E.B. Influence of intravenously administered heparin on clotting of lymph in the dog. Amer. J. Physiol. 1956; 187: 89
    PubMedGoogle Scholar
  • 17 Langdell R.D, Bowersox L.W, Weaver R.A, Gibson W.S. Coagulation properties of canine thoracic-duct lymph. Amer. J. Physiol. 1960; 199: 626
    PubMedGoogle Scholar
  • 18 Niléhn J.-E, Robertson B. On the degradation products of fibrinogen or fibrin after infusion of streptokinase in patients with venous thrombosis. Scand. J. Haemat. 1965; 2: 267
    PubMedGoogle Scholar
  • 19 Nilsson I.M, Blombäck M, von Francken I. On an inherited autosomal haemorrhagic diathesis with antihaemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand. 1957; 159: 35
    PubMedGoogle Scholar
  • 20 Nilsson I.M, Blombäck M, Ramgren O. Haemophilia in Sweden. Acta med. scand. 1961; 170: 665
    PubMedGoogle Scholar
  • 21 Nilsson I.M, Olow B. Fibrinolysis induced by streptokinase in man. Acta chir. scand. 1962; 123: 247
    PubMedGoogle Scholar
  • 22 Olow B, Nilsson I.M. Determination of fibrinogen and fibrinogenolytic activity. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 8: 297
    PubMedGoogle Scholar
  • 23 Owren P.A, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 1951; 3: 201
    CrossrefPubMedGoogle Scholar
  • 24 Paraskevas M, Nilsson I.M, Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest. 1962; 14: 138
    CrossrefPubMedGoogle Scholar
  • 25 Stutman L.J, Dumont A.E, Shinowara G.Y. Coagulation factors in human lymph and plasma. Amer. J. med. Sci. 1965; 250: 292
    CrossrefPubMedGoogle Scholar
  • 26 Wolf P. A modification for routine laboratory use of Stefaninis method of estimating factor V in human oxalated plasma. J. clin. Path. 1953; 6: 34
    CrossrefPubMedGoogle Scholar